Bayer stops blood thinner drug trial for lack of effect in major setback, World News - AsiaOne
Por um escritor misterioso
Descrição
Germany's Bayer has aborted a large late-stage trial testing a new anti-clotting drug for lack of efficacy, dealing a fresh blow to the embattled drugmaker and throwing its most promising medium-term development project in doubt. It said in a statement late on Sunday that experimental anticoagulant asundexian, which it had hoped would generate annual sales of more than 5 billion
Germany surpasses 100,000 daily Covid-19 cases for first time, World News - AsiaOne
McLaren boss says F1 budget cap breach amounts to cheating, World News - AsiaOne
AsiaOne clinical trial News, Get the Latest clinical trial Breaking News at AsiaOne
Bayer shares plunge after blood-thinning drug trial halted
Australia PM Albanese says he has not received invitation for China visit, World News - AsiaOne
Bayer gets FDA fast track status for next-generation blood thinner
Bayer flags new blood thinner as $5 bln-plus opportunity
Moderna recalls thousands of Covid-19 vaccine doses in Europe, World News - AsiaOne
WuXi Biologics Successfully Implemented a Fully Integrated Continuous Process with a Breakthrough Productivity of ~6 g/L/day at Pilot Scale, Business News - AsiaOne
Bayer shares plunge after blood-thinning drug trial halted
de
por adulto (o preço varia de acordo com o tamanho do grupo)